GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Days Payable

China National Accord Medicines (SZSE:000028) Days Payable : 101.89 (As of Mar. 2024)


View and export this data going back to 1993. Start your Free Trial

What is China National Accord Medicines Days Payable?

China National Accord Medicines's average Accounts Payable for the three months ended in Mar. 2024 was ¥19,001 Mil. China National Accord Medicines's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥17,017 Mil. Hence, China National Accord Medicines's Days Payable for the three months ended in Mar. 2024 was 101.89.

The historical rank and industry rank for China National Accord Medicines's Days Payable or its related term are showing as below:

SZSE:000028' s Days Payable Range Over the Past 10 Years
Min: 76.41   Med: 89.6   Max: 104.26
Current: 104.26

During the past 13 years, China National Accord Medicines's highest Days Payable was 104.26. The lowest was 76.41. And the median was 89.60.

SZSE:000028's Days Payable is ranked better than
68.82% of 93 companies
in the Medical Distribution industry
Industry Median: 72.99 vs SZSE:000028: 104.26

China National Accord Medicines's Days Payable increased from Mar. 2023 (91.73) to Mar. 2024 (101.89). It may suggest that China National Accord Medicines delayed paying its suppliers.


China National Accord Medicines Days Payable Historical Data

The historical data trend for China National Accord Medicines's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Days Payable Chart

China National Accord Medicines Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 86.19 95.35 96.59 90.38 91.17

China National Accord Medicines Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 91.73 98.24 111.83 106.01 101.89

Competitive Comparison of China National Accord Medicines's Days Payable

For the Medical Distribution subindustry, China National Accord Medicines's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China National Accord Medicines's Days Payable Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, China National Accord Medicines's Days Payable distribution charts can be found below:

* The bar in red indicates where China National Accord Medicines's Days Payable falls into.



China National Accord Medicines Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

China National Accord Medicines's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (15232.999 + 17952.052) / 2 ) / 66425.426*365
=16592.5255 / 66425.426*365
=91.17

China National Accord Medicines's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (17952.052 + 20050.082) / 2 ) / 17017.097*365 / 4
=19001.067 / 17017.097*365 / 4
=101.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Accord Medicines Days Payable Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.
Executives
Su Wei Wei Independent director
Chen Chang Bing Secretary Dong
Peng Juan Director
Fu Ming Zhong Director

China National Accord Medicines (SZSE:000028) Headlines

No Headlines